Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,059
  • Shares Outstanding, K 27,221
  • Annual Sales, $ 55,310 K
  • Annual Income, $ -31,190 K
  • 60-Month Beta 2.12
  • Price/Sales 2.51
  • Price/Cash Flow N/A
  • Price/Book 2.51
Trade STIM with:

Options Overview Details

View History
  • Implied Volatility 77.29% ( -41.13%)
  • Historical Volatility 52.50%
  • IV Percentile 35%
  • IV Rank 14.91%
  • IV High 470.91% on 09/19/22
  • IV Low 8.34% on 09/14/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,937
  • Open Int (30-Day) 2,343

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.43
  • Number of Estimates 2
  • High Estimate -0.43
  • Low Estimate -0.43
  • Prior Year -0.29
  • Growth Rate Est. (year over year) -48.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.71 +7.01%
on 01/20/23
6.95 -12.11%
on 01/10/23
-0.76 (-11.06%)
since 12/30/22
3-Month
3.27 +87.14%
on 11/04/22
6.95 -12.11%
on 01/10/23
+2.65 (+76.59%)
since 11/01/22
52-Week
1.98 +208.59%
on 05/10/22
6.95 -12.11%
on 01/10/23
+2.49 (+68.78%)
since 02/01/22

Most Recent Stories

More News
5 Winning Medical Product Stocks That Still Have Room to Run

Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain from...

CAH : 76.38 (-1.13%)
STIM : 6.10 (+3.74%)
SILK : 55.09 (+1.34%)
TMDX : 62.25 (-1.22%)
OLK : 19.38 (-1.02%)
Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year?

Here is how Neuronetics (STIM) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.

STIM : 6.10 (+3.74%)
CABA : 12.36 (+1.39%)
Neuronetics (STIM) Is Up 12.75% in One Week: What You Should Know

Does Neuronetics (STIM) have what it takes to be a top stock pick for momentum investors? Let's find out.

STIM : 6.10 (+3.74%)
New Strong Buy Stocks for November 16th

ENTX, STIM, FN, ANGN and FUTU have been added to the Zacks Rank #1 (Strong Buy) List on November 16, 2022.

ANGN : 0.7000 (-2.79%)
FN : 131.38 (-0.21%)
ENTX : 0.9213 (+0.36%)
STIM : 6.10 (+3.74%)
FUTU : 53.91 (+6.21%)
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 36.36% and 11.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STIM : 6.10 (+3.74%)
HTGM : 4.48 (+2.28%)
Neuronetics: Q3 Earnings Snapshot

Neuronetics: Q3 Earnings Snapshot

STIM : 6.10 (+3.74%)
Penumbra (PEN) Tops Q3 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 200% and 0.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PEN : 253.93 (+1.41%)
STIM : 6.10 (+3.74%)
Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

Glaukos (GKOS) delivered earnings and revenue surprises of 15.09% and 4.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

GKOS : 49.07 (+0.04%)
STIM : 6.10 (+3.74%)
DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates

DexCom (DXCM) delivered earnings and revenue surprises of 16.67% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

DXCM : 105.91 (-1.10%)
STIM : 6.10 (+3.74%)
Neuronetics (STIM) Just Flashed Golden Cross Signal: Do You Buy?

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

STIM : 6.10 (+3.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 6.10
2nd Resistance Point 6.04
1st Resistance Point 5.96
Last Price 6.10
1st Support Level 5.82
2nd Support Level 5.76
3rd Support Level 5.68

See More

52-Week High 6.95
Last Price 6.10
Fibonacci 61.8% 5.05
Fibonacci 50% 4.47
Fibonacci 38.2% 3.88
52-Week Low 1.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar